Ophthalmology Worldwide 2007:
Products, Technologies, Markets and
Opportunities in
Ophthalmology Surgical, Diagnostic, Device and Drug Markets Worldwide,
Forecasts 2004 - 2012
· 330 pages
· 199 Exhibits
· 103 Company Profiles
· November 2006
· Report #G125
Worldwide report on products, trends, competitors
and markets for vision disorders.
This report details
worldwide the incidence and prevalence by country/region of vision
disorders (myopia, hyperopia, presbyopia, glaucoma, cataracts and
retinal disease), and details the current and projected market for
diagnostic and therapeutic products in the management of these vision
disorders, including general vision diagnostics, diagnostics for
glaucoma, corneal and retinal disorders, and therapeutic options for
these disorders including use of pharmaceuticals, surgery and
devices. The report details current products and technologies in
use and the status of development of novel products under development.
The report details the clinical and technology developments underlying
this huge and evolving worldwide market, with data on products in
development and on the market; market size and historic/forecast 2004-2012
(actual data for 2006/2007);
competitor market shares; competitor profiles; and market
opportunity. Separate size, growth and competitor share data are
presented for the U.S., individual western European countries (UK,
Germany, France, BeNeLux, Italy and Spain),
Japan and other key international markets; Asia (India, Korea,
Australia, Russia and China), the Americas (Canada, Mexico, Brazil) and
Middle East and Africa categories. The report profiles 103 companies,
with detailed
product development, current positions and future outlook for major competitors, and brief profiles
of smaller or more development stage companies with noteworthy novel or advanced
research activities in the market.
The report establishes the market size for key international markets (as indicated
above) for major technology segments as a baseline for and projecting growth
in the market over a ten-year forecast. The report also assesses and
projects the composition of the market (shifts in share based on technology)
as technologies gain or lose relative market performance over this period.
Purchase
Executive Summary only, PDF download -- $275.00
Table of Contents
EXECUTIVE SUMMARY
Ophthalmology Background &
Market Segments
Vision Diagnostics
Eye Care Products
Cataract Surgery
Refractive Surgery
Glaucoma
Back of Eye
The Ophthalmology
Pharmaceutical Market
The Ophthalmic Device Market
Section 1:
About vision care
1.1 The Eye Care
Specialist: Optometrists & Ophthalmologists
1.2 Diagnostic Map for
Ocular Conditions
1.3 Diseases of the
Eye and Vision Conditions
1.3.1 Conditions of
the Cornea
1.3.2 Cornea
Disease Diagnostics
1.3.2.1 Visual Acuity
and General Vision Diagnostics
1.3.3 Glaucoma
1.3.3.1 Glaucoma
Diagnostics
1.3.4 Cataracts
1.3.4.1 Cataract
Diagnostics
1.3.5 Back of Eye
Disorders
1.3.5.1 Retinal
Diagnostics
Section 2:
THE MARKET FOR DIAGNOSTIC INSTRUMENTATION
2.1 Market Overview:
Diagnostic Devices
2.1.1 Hand-held
Instruments
2.1.2 Diagnostic
Equipment
Section 3:
THERAPEUTIC OPTIONS
3.1 Vision Correction
Options
3.1.1 Corrective
Lenses
3.1.1.1
Eyeglasses--The Old Standby
3.1.2 Contact
Lenses
3.1.3
Orthokeratology
3.1.4 Corneal Ring
Segments
3.1.5 Refractive
Surgery
3.1.5.1 LASIK
3.1.5.2 Custom LASIK (Wavefront-Guided
Laser Surgery)
3.1.5.3 Conductive
Keratoplasty (CK)
3.1.5.4 Laser
Epithelial Keratomileusis (LASEK)
3.1.5.5 PHAKIC IOLs
3.1.5.6
Photorefractive Keratectomy (PRK)
3.1.5.7 Laser Thermal
Keratoplasty (LTK)
3.2 Glaucoma Treatment
Approaches
3.2.1
Pharmaceutical therapy
3.2.2
Interventional Therapy
3.3 Cornea Diseases
and Treatment Options
3.3.1 Allergies
3.3.2
Conjunctivitis (Pink Eye)
3.3.3 Corneal
Infections
3.3.4 Dry Eye
3.3.5 Corneal
Dystrophies
3.3.5.1 Fuchs'
Dystrophy
3.3.5.2 Keratoconus
3.3.5.3 Corneal
Transplants
3.3.5.4 Lattice
Dystrophy
3.3.5.5
Map-dot-fingerprint Dystrophy
3.3.6 Ocular Herpes
3.3.7 Herpes Zoster
(Shingles)
3.3.8 Pterygium
3.3.9
Stevens-Johnson Syndrome
3.4 Cataract Treatment
Options
3.4.1 Cataract
Surgery
3.4.1.1
Phacoemulsification
3.4.1.2 Hand-held
Instruments
3.4.1.3 Intraocular
Lenses (IOLs)
3.5 Back of the Eye
Disease and Treatment Options
3.5.1 Macular
Degeneration
3.5.1.1 Wet and Dry
Forms of Macular Degeneration
3.5.1.2 Retinal
Detachment
3.5.2 Treatment of
Retinal Detachments
3.5.2.1 Laser
Photocoagulation
3.5.2.2 Cryopexy
3.5.2.3 Pneumatic
Retinopexy
3.5.2.4 Scleral Buckle
3.5.2.5 Pharmaceutical
Treatments for Wet AMD
Section 4:
Incidence/Prevalence of Ophthalmic Disorders
4.1 Worldwide
Incidence and Prevalence of Vision Disorders
4.1.1 The
Americas: Vision Disorders
4.1.2 The
Americas: Keratoconus
4.1.3
Europe
4.1.3.1
Vision Disorders: Europe
4.1.3.2
Keratoconus: Europe
4.1.4 Asia/Pacific
4.1.4.1 Vision
Disorders: Asia/Pacific
4.1.4.2 Keratoconus:
Asia/Pacific
4.1.5 Middle East
and Africa
4.1.5.1 Vision
Disorders: Middle East & Africa
4.1.5.2 Keratoconus:
Middle East & Africa
4.2 Worldwide
Incidence and Prevalence of Glaucoma
4.2.1 The Americas
4.2.2 Europe
4.2.3 Asia/Pacific
4.2.4 Middle East
and Africa
4.3 Cataracts
4.3.1 Cataracts:
The Americas
4.3.2 Cataracts:
Europe
4.3.3 Cataracts:
Asia/Pacific
4.3.4 Cataracts:
Middle East & Africa
4.4 Retinal Disease
4.4.1 Retinal
Disease: The Americas
4.4.2 Retinal
Disease: Europe
4.4.3 Retinal
Disease: Asia/Pacific
4.4.4 Retinal
Disease: Middle East & Africa
Section 5:
THE MARKET FOR OPHTHALMOLOGY PRODUCTS
5.1 Demand for
Products and Services
5.2 Global Market for
Ophthalmic Products
5.2.1 Refractive
Surgery
5.2.1.1 Microkeratomes
5.2.1.2 Flap Cutting
Lasers
5.2.1.3 Ablation
Lasers
5.2.1.4 Glaucoma
5.2.1.5 Cataract
5.2.1.6
Phacoemusification
5.2.1.7 Hand-held
Instruments
5.2.2 Implantable
Devices
5.2.2.1 IOLs
5.2.2.2 Back of Eye
5.3 Global Market for
Ophthalmic Diagnostic Equipment
5.3.1 Ophthalmic
Diagnostic Instrument Market, Americas
5.3.1.1 USA:
Ophthalmic Diagnostic Instrument Market
5.3.1.2 USA:
Ophthalmic Diagnostic Instrument Market Share (%) by Company
5.3.1.3 Non-USA
Americas: Ophthalmic Diagnostic Instrument Market
5.3.1.4 Non-USA
Americas: Diagnostic Instrument
Market Share (%) by Company
5.3.2 Ophthalmic
Diagnostic Instrument Market, Europe
5.3.2.1 UNITED
KINGDOM: Ophthalmic Diagnostic Instrument Market
5.3.2.2 UNITED
KINGDOM: Ophthalmic Diagnostic Instrument Market Share (%) by Company
5.3.2.3 GERMANY:
Ophthalmic Diagnostic Instrument Market
5.3.2.4 GERMANY:
Ophthalmic Diagnostic Market Share (%) by Company
5.3.2.5 FRANCE:
Ophthalmic Diagnostic Market Share (%) by Company
5.3.2.6 BENELUX:
Ophthalmic Diagnostic Instrument Market
5.3.2.7 BENELUX:
Ophthalmic Diagnostic Market Share (%) by Company
5.3.2.8 ITALY:
Ophthalmic Diagnostic Instrument Market
5.3.2.9 ITALY:
Ophthalmic Diagnostic Market Share (%) by Company
5.3.2.10 SPAIN:
Ophthalmic Diagnostic Instrument Market
5.3.2.11 SPAIN:
Diagnostic Market Share (%) by Company
5.3.2.12 EUROPE:
Ophthalmic Diagnostic Instrument Market
5.3.3 Ophthalmic
Diagnostic Instrument Market, Asia-Pacific
5.3.3.1 JAPAN:
Ophthalmic Diagnostic Instrument Market
5.3.3.2 JAPAN:
Ophthalmic Diagnostic Market Share (%) by Company
5.3.3.3 Non-Japan
ASIA-PACIFIC: Ophthalmic Diagnostic Instrument Market
5.3.3.4 Non-Japan
ASIA-PACIFIC: Ophthalmic Diagnostic Market Share (%) by Company
5.3.3.5 TOTAL Asia
Pacific: Ophthalmic Diagnostic Instrument Market
5.3.4 Worldwide:
Ophthalmic Diagnostic Instrument Market by Company
5.4 Global Market for
Cataract Surgery
5.4.1 Cataract
Surgery Market, Americas
5.4.1.1 USA Cataract
Surgery Market
5.4.1.2 USA: Cataract
Surgery Market Share (%) by Company
5.4.1.3 Non-USA
Americas: Cataract Surgery Market
5.4.1.4 Non-USA
Americas: Cataract Surgery Market Share (%) by Company
5.4.1.5 AMERICAS:
Total Cataract Surgery Market ($Millions) by Company
5.4.2 Cataract
Surgery Market, Europe
5.4.2.1 UNITED
KINGDOM: Cataract Surgery Market
5.4.2.2 UNITED
KINGDOM: Cataract Surgery Market Share (%) by Company
5.4.2.3 GERMANY:
Cataract Surgery Market
5.4.2.4 GERMANY:
Cataract Surgery Market Share (%) by Company
5.4.2.5 FRANCE:
Cataract Surgery Market
5.4.2.6 FRANCE:
Cataract Surgery Market Share (%) by Company
5.4.2.7 BENELUX
Cataract Surgery Market
5.4.2.8 BENELUX:
Cataract Surgery Market Share (%) by Company
5.4.2.9 ITALY Cataract
Surgery Market
5.4.2.10 ITALY:
Cataract Surgery Market Share (%) by Company
5.4.2.11 SPAIN Cataract
Surgery Market
5.4.2.12 SPAIN:
Cataract Surgery Market Share (%) by Company
5.4.2.13 EUROPE,
Cataract Surgery Product Revenues By Company
5.4.3 Cataract
Surgery Market, Asia-Pacific
5.4.3.1 JAPAN Cataract
Surgery Market
5.4.3.2 JAPAN:
Cataract Surgery Market Share (%) by Company
5.4.3.3 Non-Japan
ASIA-PACIFIC: Cataract Surgery Market
5.4.3.4 Non-Japan
ASIA-PACIFIC: Cataract Surgery Market Share (%) by Company
5.4.3.5 TOTAL Asia
Pacific: Cataract Surgery Market Revenues ($Millions US) by Company
5.4.4 Worldwide:
Cataract Surgery Market by Company
5.5 Global Market for
Refractive Surgery
5.5.1 Refractive
Surgery Market, Americas
5.5.1.1 U.S.
Refractive Surgery Market
5.5.1.2 U.S.
Refractive Surgery Market Share (%) by Company
5.5.1.3 Non-USA
Americas: Refractive Surgery Market
5.5.1.4 Non-USA
Americas: Refractive Surgery Market Share (%) by Company
5.5.1.5 AMERICAS:
Total Refractive Surgery Revenues by Company
5.5.2 Refractive
Surgery Market, Europe
5.5.2.1 UNITED
KINGDOM: Refractive Surgery Market
5.5.2.2 UNITED
KINGDOM: Refractive Surgery Market Share (%) by Company
5.5.2.3 GERMANY:
Refractive Surgery Market
5.5.2.4 GERMANY:
Refractive Surgery Market Share (%) by Company
5.5.2.5 FRANCE:
Refractive Surgery Market
5.5.2.6 FRANCE:
Refractive Surgery Market Share (%) by Company
5.5.2.7 BENELUX:
Refractive Surgery Market
5.5.2.8 BENELUX:
Refractive Surgery Market Share (%) by Company
5.5.2.9 ITALY:
Refractive Surgery Market
5.5.2.10 ITALY:
Refractive Surgery Market Share (%) by Company
5.5.2.11 SPAIN:
Refractive Surgery Market
5.5.2.12 SPAIN:
Refractive Surgery Market Share (%) by Company
5.5.2.13 EUROPE:
Refractive Surgery Market by Company
5.5.3 Refractive
Surgery Market, Asia-Pacific
5.5.3.1 JAPAN:
Refractive Surgery Market by Company
5.5.3.2 JAPAN:
Refractive Market Share (%) by Company
5.5.3.3 Non-Japan
ASIA-PACIFIC: Refractive Surgery Market by Country
5.5.3.4 Non-Japan
ASIA-PACIFIC: Refractive Market Share (%) by Company
5.5.3.5 TOTAL Asia
Pacific: Refractive Market by Company
5.5.4 Worldwide:
Refractive Surgery Market by Company
5.6 Global Market for
Ophthalmic Pharmaceuticals
5.6.1 Ophthalmic
Pharmaceuticals Market, Americas
5.6.1.1 U.S.
Ophthalmic Pharmaceutical Market
5.6.1.2 U.S.
Ophthalmic Pharmaceutical Market Share (%) by Company
5.6.1.3 U.S.
Ophthalmic Pharmaceutical Market by Segment
5.6.1.4 Non-USA
Americas: Ophthalmic Pharmaceutical Market
5.6.1.5 Non-USA
Americas: Ophthalmic Pharmaceutical Market Share (%) by Company
5.6.1.6 Non-USA
Americas: Ophthalmic Pharmaceutical Market by Segment
5.6.1.7 AMERICAS:
Ophthalmic Pharmaceutical Market by Segment
5.6.2 Ophthalmic
Pharmaceuticals Market, Europe
5.6.2.1 UNITED
KINGDOM: Ophthalmic Pharmaceutical Market
5.6.2.2 UNITED
KINGDOM: Ophthalmic Pharmaceutical Market Share (%) by Company
5.6.2.3 GERMANY:
Ophthalmic Pharmaceutical Market
5.6.2.4 GERMANY:
Ophthalmic Pharmaceutical Market Share (%) by Company
5.6.2.5 FRANCE:
Ophthalmic Diagnostic Instrument Market
5.6.2.6 FRANCE:
Ophthalmic Pharmaceutical Market
5.6.2.7 FRANCE:
Ophthalmic Pharmaceutical Market Share (%) by Company
5.6.2.8 BENELUX:
Ophthalmic Pharmaceutical Market
5.6.2.9 BENELUX:
Ophthalmic Pharmaceutical Market Share (%) by Company
5.6.2.10 ITALY:
Ophthalmic Pharmaceutical Market
5.6.2.11 ITALY:
Ophthalmic Pharmaceutical Market Share (%) by Company
5.6.2.12 SPAIN:
Ophthalmic Pharmaceutical Market
5.6.2.13 SPAIN:
Ophthalmic Pharmaceutical Market Share (%) by Company
5.6.2.14 EUROPE:
Ophthalmic Pharmaceutical Market by Company
5.6.2.15 EUROPE:
Ophthalmic Pharmaceutical Market by Segment
5.6.3 Ophthalmic
Pharmaceuticals Market, Asia-Pacific
5.6.3.1 JAPAN:
Ophthalmic Pharmaceutical Market by Company
5.6.3.2 JAPAN:
Ophthalmic Pharmaceutical Market Share (%) by Company
5.6.3.3 Non-Japan
ASIA-PACIFIC: Ophthalmic Pharmaceutical Market by Company
5.6.3.4 Non-Japan
ASIA-PACIFIC: Ophthalmic Pharmaceutical Market Share (%) by Company
5.6.3.5 TOTAL Asia
Pacific: Ophthalmic Pharmaceutical Market by Company
5.6.3.6 TOTAL Asia
Pacific: Ophthalmic Pharmaceutical Market by Segment
5.6.4 Worldwide:
Ophthalmic Pharmaceutical Market
5.6.4.1 Worldwide:
Ophthalmic Pharmaceutical Market by Company
5.6.4.2 Worldwide:
Ophthalmic Pharmaceutical Market by Segment
Section 6:
Company Profiles
6.1 Leading Companies
6.1.1 Advanced
Medical Optics
6.1.1.1 Overview
6.1.1.2 Products
6.1.1.3 Pipeline
6.1.1.4 Financials
6.1.2 Alcon
Laboratories, Inc.
6.1.2.1 Overview
6.1.3 Allergan
6.1.3.1 Overview
6.1.3.2 Products
6.1.3.3 Pipeline
6.1.3.4 Financials
6.1.4 Bausch & Lomb
6.1.4.1 Overview
6.1.4.2 Products
6.1.4.3 Pipeline
6.1.4.4 Financials
6.1.5 Carl Zeiss
Meditech
6.1.5.1 Overview
6.1.5.2 Products
6.1.5.3 Pipeline
6.1.5.4 Financials
6.1.6 IntraLase,
Inc.
6.1.6.1 Overview
6.1.6.2 Products
6.1.6.3 Pipeline
6.1.6.4 Financials
6.1.7 STAAR
Surgical
6.1.7.1 Overview
6.1.7.2 Products
6.1.7.3 Pipeline
6.1.7.4 Financials
6.1.8 Iridex
Corporation
6.1.8.1 Overview
6.1.8.2 Products
6.1.8.3 Pipeline
6.1.8.4 Financials
6.2 Other Companies
6.2.1 Acufocus
6.2.2 Addition
Technology, Inc.
6.2.3 Advanced Cell
Tech, Inc.
6.2.4 American
Optisurgical, Inc. (AOI)
6.2.5 Aquasys, Inc
6.2.6 BD Medical
Ophthalmic
6.2.7 Biosyntrx,
Inc.
6.2.8 Calhoun
Vision
6.2.9 CustomVis
6.2.10 Eagle Vision
6.2.11 Eli Lilly
6.2.12 Endo Optiks,
Inc.
6.2.13 Escalon
Medical Imaging
6.2.14 EyeKon Medical
6.2.15 Eyemaginations
6.2.16 Eyeonics, Inc.
6.2.17 EyeSys Vision,
Inc.
6.2.18 FCI
Ophthalmics
6.2.19 Genentech
6.2.20 Geuder AG
6.2.21 Glaukos
6.2.22 Haag-Streit
6.2.23 Heidelberg
Engineering, Inc.
6.2.24 Heine
6.2.25 Howard
Instruments
6.2.26 Huvitz
6.2.27 IOP, Inc.
6.2.28 IRIDEX
6.2.29 iScience
Interventional
6.2.30 ISTA
Pharmaceuticals
6.2.31 Keeler
Instruments
6.2.32 Kowa Optimed
6.2.33 Lacrimedics
6.2.34 Leica
Microsystems
6.2.35 Lenstec Inc
6.2.36 Lumenis
6.2.37 MacuScope
6.2.38 MacuSight,
Inc.
6.2.39 Marco
6.2.40 Mastel
Precision
6.2.41 Medennium
6.2.42 Micro Medical
Devices, Inc
6.2.43 Moeller-Wedel.
6.2.44 MST
6.2.45 Neitz
Instruments Co
6.2.46 NeoMedix
6.2.47 NeoVista
6.2.48 New World
Medical
6.2.49 Nidek, Inc.
6.2.50
Novadaq Technologies
6.2.51
Novartis Ophthalmics
6.2.52
NovaVision Inc.
6.2.53 OASIS Medical
6.2.54 OccuLogix
6.2.55 OculusGen
Biomedical
6.2.56 Odyssey
Medical
6.2.57 Omni
Lens
6.2.58
Ophtec
6.2.59
Optikon 2000 s.p.a.
6.2.60 Optimedica
6.2.61 Optos, Inc.
6.2.62 Optovue.
6.2.63 Pelion
Surgical
6.2.64 Pfizer
Ophthalmics
6.2.65 Quest Medical
6.2.66 Refractec
6.2.67 Reichert
6.2.68 Regeneron
Pharmaceuticals
6.2.69 Rhein Medical
6.2.70 Santen, Inc.
6.2.71 Scan Optics
6.2.72 Schwind
Eye-tech Solutions
6.2.73 ScyFIX
6.2.74 Second Sight
6.2.75 Sirion
Holdings, Inc. (formerly Sirion Therapeutics)
6.2.76 Sonogage
6.2.77 Sonomed.
6.2.78 Stereo Optical
Company, Inc.
6.2.79 STAAR Surgical
6.2.80 Surmodics
6.2.81 Synemed
6.2.82 Tekia
6.2.83 Titan Surgical
6.2.84 Tomey
6.2.85 Topcon Medical
Systems (TMS)
6.2.86 Tracey
Technologies
6.2.87 Trevi
Technology
6.2.88 Visiogen, Inc.
6.2.89 Vistakon
6.2.90 Vistakon
Pharmaceuticals, LLC
6.2.91 Visual
Pathways
6.2.92 WaveLight AG
6.2.93 Welch Allyn
6.2.94 Woodlyn, Inc.
6.2.95 Ziemer
Ophthalmic Systems AG.
Appendix: Company Addresses
APPENDIX A: Worldwide
Prevalence of Vision Disorders
APPENDIX B: Worldwide
Prevalence of Keratoconus
APPENDIX C: Worldwide
Prevalence of Glaucoma
APPENDIX D: Worldwide
Prevalence of Cataracts
APPENDIX E: Worldwide
Prevalence of Back of Eye Disorders
List of Exhibits
Exhibit ES-1: Total
Ophthalmic Products Market by Segment, 2006
Exhibit ES-2: Ophthalmic
Product Revenues (Diagnostics, Surgical, Pharmaceuticals) by Country/Region
Exhibit 1-1: Optometrist
Practice by Type
Exhibit 1-2:
Ophthalmologists by Sub-Specialty
Exhibit 1-3: Practicing
Ophthalmologists by Type of Practice/Role
Exhibit 1-4:
Ophthalmologists by Practice Type
Exhibit 1-5:
Cross-Sectional Schematic of the Human Eye
Exhibit 1-6: Snellen Eye
Chart
Exhibit 2-1: Hand-Held
Instrument Category Offerings, by Manufacturer
Exhibit 2-2: Diagnostic
Equipment Used by the Eye Care Professional and Average Selling Prices
Exhibit 2-3: Worldwide
Diagnostic Instrumentation Revenue, U.S. and Non-U.S., by Segment, 2006
Exhibit 2-4: Diagnostic
Instrumentation Offerings, By Manufacturer
Exhibit 2-5: Percent of
Ophthalmic Diagnostic Equipment Sold to O.D. vs M.D. in US vs International
(OUS) Markets
Exhibit 3-1: Manufacturers
of Corneal Reshaping Lenses
Exhibit 3-2: Manufacturers
of Implantable Corneal Ring Segment Products for Vision Correction
Exhibit 3-3: LASIK Products
and Manufacturers
Exhibit 3-4: Products Used
in Custom Ablation LASIK
Exhibit 3-5: Phakic IOL
Manufacturers and Products
Exhibit 3-6: Products for
Non-LASIK Refractive Surgery Procedures
Exhibit 3-7: Open-Angle
Glaucoma Prevalence Rates by Age and Race
Exhibit 3-8: Share of U.S.
Glaucoma Medication Sales by Type, 2005
Exhibit 3-9: Glaucoma
Pharmaceutical Products
Exhibit 3-10: Medical
Device Products for the Treatment of Glaucoma
Exhibit 3-11: U.S. Glaucoma
Treatment Procedures by Type, 2006
Exhibit 3-12:
Pharmaceutical Allergy Medications
Exhibit 3-13:
Anti-Infective and Anti-Inflammatory Ophthalmic Pharmaceutical Products
Exhibit 3-14: Products for
the Treatment of Dry Eye
Exhibit 3-15: Ophthalmic
Drugs by Type, 2004 & 2008
Exhibit 3-16:
Phacoemulsification Systems for Cataract Surgery, U.S. and Rest of World,
2006
Exhibit 3-17:
Phacoemulsification Equipment and Accessories
Exhibit 3-18: Conventional
Intraocular Lens Manufacturers and Products
Exhibit 3-19: IOL Accessory
Manufacturers and Products
Exhibit 3-20: Cataract
Surgery Procedures, U.S. and Worldwide, 2003-2008
Exhibit 3-21: Multifocal
IOL Manufacturers and Products
Exhibit 3-22: Phakic IOL
Products and Manufacturers
Exhibit 3-23:
Pharmaceuticals to Treat Age-related Macular Degeneration
Exhibit 3-24: Alternatives
to Pharmaceutical Developments for the Treatment of Wet AMD
Exhibit 3-25: Manufacturers
of Equipment for the Treatment of Retinal Disorders
Exhibit 4-1: The Americas,
Prevalence of Vision Disorders
Exhibit 4-2: The Americas,
Prevalence of Keratoconus
Exhibit 4-3: Europe,
Prevalence of Vision Disorders
Exhibit 4-4: Europe,
Prevalence of Keratoconus, by Country
Exhibit 4-5: Asia-Pacific,
Prevalence of Vision Disorders
| 
